Embryo Ventures is a London-based venture capital firm founded in 2019, dedicated to investing in transformative companies at the seed and pre-seed stages. The firm focuses on sectors such as Health, Living, and Cities, aiming to back exceptional founders driven by purpose and bold visions. Embryo Ventures emphasizes the sustainable development of health, environments, and living patterns, seeking ventures that enable transformations across consumer, industry, and health systems.

Notable investments include PLUVO, Cheeky Panda, Thermulon, NOVARA, TasteIndex, Calla Lily Clinical Care, LAKA, BioLumen, OSSTEC, STAXY, and OSTIQUE. The firm is committed to being active partners with founders, providing value beyond capital, and focusing on ventures that solve societal needs and drive positive, sustainable transformations globally.